League City, TX, United States of America

Partha Sarkar

This inventor holds 2 USPTO granted patents. Top assignee: The University of Texas System. Active years: 2012-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Partha Sarkar. Retrieved from https://idiyas.com/inventor/partha-sarkar-g3i00m7w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Partha Sarkar: Innovator in Nucleotide Repeat Disorders

Introduction

Partha Sarkar is a notable inventor based in League City, TX (US). He has made significant contributions to the field of biotechnology, particularly in the area of nucleotide repeat disorders. With a total of 2 patents, his work focuses on developing methods and compositions that can lead to therapeutic advancements.

Latest Patents

Sarkar's latest patents revolve around methods and compositions involving nucleic acids with long repeat sequences. The inventions detail methods for generating such nucleic acids and their applications in screening for candidate therapeutic compounds. Additionally, these patents include methods for screening Notch inhibitors and other substances that may be utilized to treat muscle loss and wasting.

Career Highlights

Partha Sarkar is affiliated with the University of Texas System, where he continues to engage in innovative research. His work has the potential to impact the treatment of various genetic disorders, showcasing his commitment to advancing medical science.

Collaborations

Sarkar has collaborated with esteemed colleagues such as Weidong Xu and Tetsuo Ashizwa. These partnerships enhance the scope and impact of his research endeavors.

Conclusion

Partha Sarkar's contributions to the field of nucleotide repeat disorders exemplify the importance of innovation in biotechnology. His patents and ongoing research hold promise for future therapeutic developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…